Terumo

Incorporated in 1921, the global entity with headquarters in Shibuya, Tokyo, Japan, operates primarily in the healthcare sector, diversified into three main business categories. The Cardiac and Vascular Company focuses on interventional systems, vascular grafts, and surgical products for cardiac and vascular procedures. The General Hospital Company provides a spectrum of products that includes infusion and transfusion systems, clinical testing devices, and medical electronic equipment. The Blood and Cell Technologies segment is tailored to advancing blood component, therapeutic apheresis, and cellular technologies. This entity is known for its influential brands such as Terumo BCT, which leads in blood component and cellular technology solutions; Terumo Cardiovascular, which delivers cardiac and vascular surgery products; and Terumo Interventional Systems, recognized for its extensive range of interventional medical devices. While the company commands a prominent position in its home country of Japan, it has also established a substantial footprint in the United States, various European and Asian countries, and in the markets of Latin America, making it a significant player in the global healthcare industry with reach extending to over 160 countries worldwide. (Powered by AI)